349 related articles for article (PubMed ID: 30245264)
1. Galectins as regulators of cell survival in the leukemia niche.
Ruvolo PP
Adv Biol Regul; 2019 Jan; 71():41-54. PubMed ID: 30245264
[TBL] [Abstract][Full Text] [Related]
2. Role of MSC-derived galectin 3 in the AML microenvironment.
Ruvolo PP; Ruvolo VR; Burks JK; Qiu Y; Wang RY; Shpall EJ; Mirandola L; Hail N; Zeng Z; McQueen T; Daver N; Post SM; Chiriva-Internati M; Kornblau SM; Andreeff M
Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(7):959-969. PubMed ID: 29655803
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis: Tim-3/galectin-9, a new pathway for leukemia stem cells survival by promoting expansion of myeloid-derived suppressor cells and differentiating into tumor-associated macrophages.
Gao L; Yu S; Zhang X
Cell Biochem Biophys; 2014 Sep; 70(1):273-7. PubMed ID: 24639110
[TBL] [Abstract][Full Text] [Related]
4. Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival.
Kornblau SM; Ruvolo PP; Wang RY; Battula VL; Shpall EJ; Ruvolo VR; McQueen T; Qui Y; Zeng Z; Pierce S; Jacamo R; Yoo SY; Le PM; Sun J; Hail N; Konopleva M; Andreeff M
Haematologica; 2018 May; 103(5):810-821. PubMed ID: 29545342
[TBL] [Abstract][Full Text] [Related]
5. Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.
Ruvolo PP; Ruvolo VR; Benton CB; AlRawi A; Burks JK; Schober W; Rolke J; Tidmarsh G; Hail N; Davis RE; Andreeff M
Biochim Biophys Acta; 2016 Apr; 1863(4):562-71. PubMed ID: 26704388
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
7. Galectin 3 as a guardian of the tumor microenvironment.
Ruvolo PP
Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
[TBL] [Abstract][Full Text] [Related]
8. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
[TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
Front Immunol; 2021; 12():746492. PubMed ID: 34737747
[TBL] [Abstract][Full Text] [Related]
10. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression].
Kikushige Y
Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443
[TBL] [Abstract][Full Text] [Related]
11. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
[TBL] [Abstract][Full Text] [Related]
12. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia.
Kim JA; Shim JS; Lee GY; Yim HW; Kim TM; Kim M; Leem SH; Lee JW; Min CK; Oh IH
Cancer Res; 2015 Jun; 75(11):2222-31. PubMed ID: 25791383
[TBL] [Abstract][Full Text] [Related]
13. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
[TBL] [Abstract][Full Text] [Related]
14. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
[TBL] [Abstract][Full Text] [Related]
16. Role of Microenvironment in Resistance to Therapy in AML.
Tabe Y; Konopleva M
Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.
Sioud M; Mobergslien A; Boudabous A; Fløisand Y
Int J Oncol; 2011 Feb; 38(2):385-90. PubMed ID: 21165555
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
[TBL] [Abstract][Full Text] [Related]
19. Role of Galectins in Multiple Myeloma.
Storti P; Marchica V; Giuliani N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
[TBL] [Abstract][Full Text] [Related]
20. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
